Insider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) CFO Sells 682 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) CFO David T. Doherty sold 682 shares of the firm’s stock in a transaction on Monday, March 13th. The shares were sold at an average price of $29.86, for a total value of $20,364.52. Following the completion of the transaction, the chief financial officer now owns 82,427 shares in the company, valued at approximately $2,461,270.22. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Surgery Partners Stock Performance

Shares of Surgery Partners stock opened at $31.25 on Friday. The firm has a market cap of $3.94 billion, a PE ratio of -53.88 and a beta of 2.73. The company has a quick ratio of 1.72, a current ratio of 1.87 and a debt-to-equity ratio of 0.87. Surgery Partners, Inc. has a 52 week low of $20.46 and a 52 week high of $63.87. The business’s fifty day simple moving average is $32.96 and its 200-day simple moving average is $28.85.

Surgery Partners (NASDAQ:SGRY – Get Rating) last issued its quarterly earnings data on Wednesday, March 1st. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.06. The firm had revenue of $707.10 million for the quarter, compared to analyst estimates of $688.34 million. Surgery Partners had a negative net margin of 2.15% and a negative return on equity of 0.14%. Equities analysts forecast that Surgery Partners, Inc. will post 0.4 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on SGRY shares. Stifel Nicolaus decreased their price target on shares of Surgery Partners from $44.00 to $36.00 in a research note on Tuesday, November 22nd. Barclays lowered their target price on Surgery Partners from $69.00 to $56.00 and set an “overweight” rating on the stock in a report on Wednesday, January 18th. StockNews.com started coverage on Surgery Partners in a research report on Thursday. They issued a “sell” rating for the company. JPMorgan Chase & Co. reduced their price objective on Surgery Partners from $45.00 to $40.00 and set a “neutral” rating on the stock in a research report on Thursday, March 2nd. Finally, Citigroup upped their target price on Surgery Partners from $38.00 to $40.00 in a report on Thursday, March 2nd. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $42.00.

Hedge Funds Weigh In On Surgery Partners

A number of hedge funds have recently made changes to their positions in SGRY. Durable Capital Partners LP raised its position in Surgery Partners by 174.3% in the fourth quarter. Durable Capital Partners LP now owns 5,853,995 shares of the company’s stock valued at $163,092,000 after purchasing an additional 3,719,766 shares during the period. Avidity Partners Management LP raised its holdings in shares of Surgery Partners by 1,062.9% in the 4th quarter. Avidity Partners Management LP now owns 3,112,000 shares of the company’s stock valued at $86,700,000 after buying an additional 2,844,400 shares during the period. FMR LLC lifted its stake in Surgery Partners by 13.5% during the 2nd quarter. FMR LLC now owns 13,484,523 shares of the company’s stock worth $389,972,000 after acquiring an additional 1,606,776 shares in the last quarter. Point72 Asset Management L.P. lifted its stake in Surgery Partners by 268.8% during the 4th quarter. Point72 Asset Management L.P. now owns 2,193,423 shares of the company’s stock worth $61,109,000 after acquiring an additional 1,598,658 shares in the last quarter. Finally, Clearbridge Investments LLC boosted its holdings in Surgery Partners by 24.8% during the 4th quarter. Clearbridge Investments LLC now owns 5,479,317 shares of the company’s stock valued at $152,654,000 after acquiring an additional 1,088,289 shares during the period.

Surgery Partners Company Profile

(Get Rating)

Surgery Partners, Inc is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services.